Chen Xin, Zhang Li-Ping, Wang Xiao-Long, Zhang Ning-Ru, Yu Jing, Xu Li-Ying, Li Tong-She, Luan Hong, Zhang Juan, Hu Ya-Min, Liu Dan, Zheng Qi-Dong, Li Yan, Wang Ji-Guang
Department of Cardiovascular Medicine, The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Department of Internal Medicine, Hospital of Shanxi Datong University, Shanxi, China.
J Clin Hypertens (Greenwich). 2025 Jan;27(1):1-4. doi: 10.1111/jch.14919. Epub 2024 Oct 22.
We reported the blood pressure data obtained in the May Measurement Month (MMM) China project in 2020 during the COVID-19 control period. The study participants were adults (≥ 18 years), ideally in whom blood pressure had not been measured in the previous year. Blood pressure was measured three times consecutively with a 1-min interval in the sitting position, using a validated automated BP monitor (Omron HEM-7081IT), and transmitted to a central database via a smartphone app. The measurement was performed at 136 sites across 29 China provinces. The 100 728 participants had a mean (±SD) age of 45.6 (±18.3) years and included 56 097 (55.7%) women. The mean systolic/diastolic blood pressure was 120.0/76.9 mm Hg. The proportion of hypertension was 28.9% (n = 29 135), and the awareness, treatment, and control rates of hypertension were 45.3% (n = 13 212), 39.7% (n = 1573), and 24.4% (n = 7101), respectively. After adjustment for age, gender, and use of antihypertensive medication, systolic/diastolic BP were significantly higher with cigarette smoking (n = 8070, +0.5/+1.0 mm Hg, p < 0.05), mild (n = 4369, +1.2/+1.3 mm Hg, p < 0.001) and moderate or heavy alcohol drinking (n = 3871, +0.4/+0.7 mm Hg, p < 0.05), and overweight (+1.8/+1.4 mm Hg, p < 0.001) and obesity (+2.3/+1.5 mm Hg, p < 0.001). In conclusion, our study provided unique blood pressure data during the COVID-19 period, and suggested that hypertension management might have been even more challenging when the medical professionals had to shift their focus on other urgencies.
我们报告了2020年新冠疫情防控期间“五月测量月”（MMM）中国项目中获取的血压数据。研究参与者为成年人（≥18岁），理想情况下是前一年未测量过血压的人。使用经过验证的自动血压监测仪（欧姆龙HEM - 7081IT），在坐位连续测量三次血压，每次间隔1分钟，并通过智能手机应用程序传输至中央数据库。测量在中国29个省份的136个地点进行。100728名参与者的平均（±标准差）年龄为45.6（±18.3）岁，其中女性56097名（55.7%）。平均收缩压/舒张压为120.0/76.9毫米汞柱。高血压患病率为28.9%（n = 29135），高血压知晓率、治疗率和控制率分别为45.3%（n = 13212）、39.7%（n = 1573）和24.4%（n = 7101）。在对年龄、性别和抗高血压药物使用情况进行调整后，吸烟（n = 8070，收缩压/舒张压分别升高0.5/1.0毫米汞柱，p < 0.05）、轻度饮酒（n = 4369，收缩压/舒张压分别升高1.2/1.3毫米汞柱，p < 0.001）以及中度或重度饮酒（n = 3871，收缩压/舒张压分别升高0.4/0.7毫米汞柱，p < 0.05）、超重（收缩压/舒张压分别升高1.8/1.4毫米汞柱，p < 0.001）和肥胖（收缩压/舒张压分别升高2.3/1.5毫米汞柱，p < 0.001）者的收缩压/舒张压显著更高。总之，我们的研究提供了新冠疫情期间独特的血压数据，并表明当医疗专业人员不得不将重点转移到其他紧急情况时，高血压管理可能面临更大挑战。
